标题
B-cell Therapy for Multiple Sclerosis: Entering an era
作者
关键词
-
出版物
ANNALS OF NEUROLOGY
Volume 83, Issue 1, Pages 13-26
出版商
Wiley
发表日期
2017-12-17
DOI
10.1002/ana.25119
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Human immune compartment comparisons: Optimization of proliferative assays for blood and gut T lymphocytes
- (2017) Jeffrey Dock et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
- (2017) Omid Mirmosayyeb et al. Journal of Research in Medical Sciences
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
- (2017) Elena Giacomini et al. Multiple Sclerosis Journal
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccines and Disease-Modifying Antirheumatic Drugs
- (2017) Marcia A. Friedman et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Safety and tolerability of inebilizumab (MEDI-551), an anti-CD19 monoclonal antibody, in patients with relapsing forms of multiple sclerosis: Results from a phase 1 randomised, placebo-controlled, escalating intravenous and subcutaneous dose study
- (2017) Mark A Agius et al. Multiple Sclerosis Journal
- Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing–remitting multiple sclerosis patients
- (2017) Elena Giacomini et al. Multiple Sclerosis Journal
- Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
- (2016) Peter Alping et al. ANNALS OF NEUROLOGY
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- Vaccinations in patients with hematological malignancies
- (2016) C. Tsigrelis et al. BLOOD REVIEWS
- Ublituximab (TG-1101), a novel glycoengineered anti-CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial
- (2016) Jeff P. Sharman et al. BRITISH JOURNAL OF HAEMATOLOGY
- Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
- (2016) Amandine Mathias et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis
- (2016) Jonatan Salzer et al. NEUROLOGY
- Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
- (2016) Simone M. Brändle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity
- (2016) Erin E. Longbrake et al. JAMA Neurology
- Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
- (2016) Amandine Mathias et al. Multiple Sclerosis Journal
- Onset of secondary progressive MS after long-term rituximab therapy - a case report
- (2016) H.-Christian von Büdingen et al. Annals of Clinical and Translational Neurology
- Rituximab for IgG4-related disease: a prospective, open-label trial
- (2015) Mollie N Carruthers et al. ANNALS OF THE RHEUMATIC DISEASES
- Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years
- (2015) R. F. van Vollenhoven et al. JOURNAL OF RHEUMATOLOGY
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Safety issues of biologics in pregnant patients with rheumatic diseases
- (2014) Monika Østensen Annals of the New York Academy of Sciences
- Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
- (2014) Zachary S Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- The Transcription Factors T-bet and Runx Are Required for the Ontogeny of Pathogenic Interferon-γ-Producing T Helper 17 Cells
- (2014) Yan Wang et al. IMMUNITY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
- (2014) Ludwig Kappos et al. LANCET NEUROLOGY
- The Charcot Lecture | Beating MS: A story of B cells, with twists and turns
- (2014) Stephen L Hauser Multiple Sclerosis Journal
- IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
- (2014) Ping Shen et al. NATURE
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety with Ocrelizumab in Rheumatoid Arthritis: Results from the Ocrelizumab Phase III Program
- (2014) Paul Emery et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination
- (2014) Janet E. Holley et al. Multiple Sclerosis and Related Disorders
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses
- (2013) Jaishree Bankoti et al. ANNALS OF NEUROLOGY
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
- (2013) I. Nazi et al. BLOOD
- PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis
- (2013) H. Benjamin Larman et al. JOURNAL OF AUTOIMMUNITY
- Specific peripheral B cell tolerance defects in patients with multiple sclerosis
- (2013) Tuure Kinnunen et al. JOURNAL OF CLINICAL INVESTIGATION
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis
- (2013) Markus Axelsson et al. JOURNAL OF NEUROIMMUNOLOGY
- Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica
- (2013) Jennifer Graves et al. Multiple Sclerosis and Related Disorders
- Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time
- (2011) Xiaoli Yu et al. JOURNAL OF NEUROIMMUNOLOGY
- Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin
- (2011) Birgit Obermeier et al. JOURNAL OF NEUROIMMUNOLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Autoantigen discovery with a synthetic human peptidome
- (2011) H Benjamin Larman et al. NATURE BIOTECHNOLOGY
- Fate mapping of IL-17-producing T cells in inflammatory responses
- (2011) Keiji Hirota et al. NATURE IMMUNOLOGY
- Rituximab monotherapy for patients with recurrent primary CNS lymphoma
- (2011) T. T. Batchelor et al. NEUROLOGY
- Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
- (2011) M. C. Kowarik et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
- (2010) F. Morschhauser et al. ANNALS OF ONCOLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
- (2010) Avijit Ray et al. JOURNAL OF NEUROIMMUNOLOGY
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid
- (2009) Gregory P. Owens et al. ANNALS OF NEUROLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases
- (2009) Eamonn S. Molloy et al. ARTHRITIS AND RHEUMATISM
- Good and bad memories following rituximab therapy
- (2009) E. William St.Clair ARTHRITIS AND RHEUMATISM
- Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis
- (2009) Jingxian Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce “oligoclonal bands”
- (2009) Hans-Christian von Büdingen et al. JOURNAL OF NEUROIMMUNOLOGY
- Development of Novel Tetravalent Anti-CD20 Antibodies with Potent Antitumor Activity
- (2008) B. Li et al. CANCER RESEARCH
- Cytokine-producing B lymphocytes—key regulators of immunity
- (2008) Frances E Lund CURRENT OPINION IN IMMUNOLOGY
- Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin‐specific antibodies
- (2008) Hans‐Christian von Büdingen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- B cells as therapeutic targets in autoimmune neurological disorders
- (2008) Marinos C Dalakas Nature clinical practice. Neurology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started